As Omeros Corp (OMER) Stock Price Declined, Ingalls & Snyder LLC Increased Its Position by $3.31 Million

April 17, 2018 - By Hannah Black

Omeros Corporation (NASDAQ:OMER) LogoInvestors sentiment decreased to 1.3 in Q4 2017. Its down 1.56, from 2.86 in 2017Q3. It dived, as 14 investors sold OMER shares while 29 reduced holdings. 31 funds opened positions while 25 raised stakes. 21.94 million shares or 0.43% less from 22.04 million shares in 2017Q3 were reported. Northern Corporation has 0% invested in Omeros Corporation (NASDAQ:OMER). Art Advsrs Ltd Company has invested 0.03% of its portfolio in Omeros Corporation (NASDAQ:OMER). Davenport & Co Ltd Co holds 79,400 shares. 195,120 are held by Chicago Equity Prns Limited Liability Corp. Malaga Cove Cap Ltd Company holds 0.14% of its portfolio in Omeros Corporation (NASDAQ:OMER) for 12,477 shares. Cypress Group has invested 0.04% in Omeros Corporation (NASDAQ:OMER). Quantbot Tech LP reported 10,495 shares or 0.02% of all its holdings. Citadel Ltd Liability, a Illinois-based fund reported 31,184 shares. National Bank & Trust Of America De reported 77,591 shares or 0% of all its holdings. National Bank Of Mellon owns 217,411 shares or 0% of their US portfolio. Morgan Stanley, New York-based fund reported 157,503 shares. Goldman Sachs owns 46,004 shares. State Board Of Administration Of Florida Retirement Sys owns 0% invested in Omeros Corporation (NASDAQ:OMER) for 30,737 shares. Jpmorgan Chase And Com reported 0% of its portfolio in Omeros Corporation (NASDAQ:OMER). Natl Bank Of Montreal Can invested 0% in Omeros Corporation (NASDAQ:OMER).

Since January 3, 2018, it had 0 buys, and 2 selling transactions for $1.36 million activity. Shares for $1.34 million were sold by Kelbon Marcia S. on Wednesday, January 3.

Ingalls & Snyder Llc increased its stake in Omeros Corp (OMER) by 3.38% based on its latest 2017Q4 regulatory filing with the SEC. Ingalls & Snyder Llc bought 174,204 shares as the company’s stock declined 39.13% with the market. The institutional investor held 5.34M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $103.66 million, up from 5.16 million at the end of the previous reported quarter. Ingalls & Snyder Llc who had been investing in Omeros Corp for a number of months, seems to be bullish on the $736.36M market cap company. The stock increased 9.48% or $1.32 during the last trading session, reaching $15.25. About 425,722 shares traded. Omeros Corporation (NASDAQ:OMER) has declined 3.39% since April 17, 2017 and is downtrending. It has underperformed by 14.94% the S&P500.

Ingalls & Snyder Llc, which manages about $3.07 billion and $2.17B US Long portfolio, decreased its stake in Goldman Sachs Group Inc (Call) (NYSE:GS) by 11,900 shares to 8,600 shares, valued at $2.19M in 2017Q4, according to the filing. It also reduced its holding in Freeport (NYSE:FCX) by 236,400 shares in the quarter, leaving it with 229,400 shares, and cut its stake in General Electric Co (NYSE:GE).

Omeros Corporation (NASDAQ:OMER) Ratings Coverage

Among 6 analysts covering Omeros (NASDAQ:OMER), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Omeros had 14 analyst reports since November 2, 2017 according to SRatingsIntel. The rating was downgraded by Cowen & Co to “Market Perform” on Thursday, November 2. As per Thursday, December 14, the company rating was maintained by H.C. Wainwright. The firm earned “Buy” rating on Tuesday, November 28 by Wedbush. The firm earned “Buy” rating on Thursday, January 4 by H.C. Wainwright. H.C. Wainwright maintained the stock with “Buy” rating in Wednesday, November 29 report. As per Thursday, March 22, the company rating was maintained by Maxim Group. The stock of Omeros Corporation (NASDAQ:OMER) earned “Neutral” rating by Wedbush on Friday, March 23. The company was downgraded on Friday, March 2 by Needham. The firm has “Buy” rating given on Friday, March 23 by H.C. Wainwright. On Monday, March 5 the stock rating was maintained by H.C. Wainwright with “Buy”.

Omeros Corporation (NASDAQ:OMER) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: